🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › Louisiana › New Orleans

Qorannoo klinikaalii Kansarii Ovarii New Orleans, LA keessatti

Qorannoo 12 Kansarii Ovarii f New Orleans fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Louisiana State University HSC - NO Cancer Center, New Orleans
Umuriin 18 fi ol · Dubartoota · Haaromfame 05-Onk-2026 · NCT06915025

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Namoota walitti qabaa jiraSadarkaa 2/3
  • University Medical Center New Orleans, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Ochsner Medical Center Jefferson, New Orleans
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564377

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Ochsner Clinic Foundation, New Orleans
Umuriin 18 fi ol · Dubartoota · Haaromfame 29-Ful-2026 · NCT05051722

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Ochsner Clinic Foundation, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213804

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Tulane Cancer Center, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Namoota walitti qabaa jira
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • West Jefferson Medical Center, Marrero · Miili 4 fagaatti
Umuriin 35 hanga 50 · Dubartoota · Haaromfame 07-Hag-2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University Medical Center New Orleans, New Orleans
  • Ochsner Baptist Medical Center, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06580314

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Louisiana State University Health Sciences Center, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT05768139

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • LSU Health New Orleans, New Orleans
  • University Medical Center New Orleans, New Orleans
Umuriin 18 fi ol · Dubartoota · Haaromfame 16-Elb-2026 · NCT05659381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, New Orleans
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Kansarii Ovarii magaalota biroo keessatti

Qorannoo biroo New Orleans keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.